Rising government investments for cell-based research, the increasing number of GMP-certified production facilities, and the large number of oncology-oriented cell-based therapy clinical trials are the key factors driving the growth of this market. China, India, Japan, Korea, and Brazil are emerging markets for cell therapy instruments. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=889 These markets boast comparatively lenient standards... Continue Reading →